Treatment of Oral Mucositis Using Platelet Rich Fibrin TREATMENT OF ORAL MUCOSITIS USING PRF

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

May 1, 2019

Study Completion Date

July 19, 2021

Conditions
Graft Vs Host DiseaseOral Mucositis (Ulcerative)Mesenchymal Stem Cells
Interventions
DEVICE

TREATMENT OF ORAL MUCOSITIS USING PLATELET-RICH-FIBRIN (PRF)

All patients were affected by oral mucositis (9 RIOM, 6 chemotherapy-related oral mucositis). They were treated with almost 2 different systemic therapies before and during platelets gel applications. Median of time before the lesions were treated with platelets gel were 7 days. Lesions affected buccal mucosa, tongue, labial commissure and lower lip. Preliminar parameters were the microbiological contamination of lesions and presence of pain. Patients refer spontaneous widespread pain worsened by swallowing and feeding. Response to treatment has been evaluated in relation to the reduction of lesions dimensions, to the involution of pain and presence of granulation tissue after every application of platelet gel.

Trial Locations (1)

73057

Francesco Gianfreda, Taviano

All Listed Sponsors
lead

University of Rome Tor Vergata

OTHER

NCT05018754 - Treatment of Oral Mucositis Using Platelet Rich Fibrin TREATMENT OF ORAL MUCOSITIS USING PRF | Biotech Hunter | Biotech Hunter